Tesnatilimab (Anti-NKG2D / CD314)

Ask supplier a question | View on supplier's website

Tesnatilimab (Anti-NKG2D / CD314) is a recombinant human immunoglobulin G4 (IgG4) monoclonal antibody against the immune activating receptor natural-killer group 2, member D receptor protein (NKG2D or KLRK1), with potential immunomodulating and anti-inflammatory activities. MW: 146.5 kD.

Supplier	Selleck Chemicals
Product #	A2390
Sku #	A2390-1mg
Pricing	1mg, $470.00

Feedback